Health News Review

Missing The Target: When Practitioners Harm More Than Heal” is the title of a two-day conference in Washington this week (June 14-15) hosted by at Georgetown.  This is their third annual conference – this one focusing on how patient harms may result from industry promotions.

The full agenda and abstracts are now available online.

Some of the speakers:

  • Rita Redberg, M.D., M.Sc., Archives of Internal Medicine Editor-in-Chief; professor of medicine, University of California, San Francisco
  • Carl Elliott, M.D. Ph.D., author, White Coat, Black Hat; professor, University of Minnesota’s Center for Bioethics
  • Kay Dickersin, Ph.D., director, Center for Clinical Trials, Johns Hopkins Center for Global Health
  • Julie Taitsman, M.D., J.D., chief medical officer, Office of the Inspector General, U.S. Department of Health and Human Services
  • Sharon Treat, J.D., executive director, National Legislative Association on Prescription Drug Prices
  • Thomas M. Burton, Pulitzer Prize winning-journalist, The Wall Street Journal
  • Shannon Brownlee, M.S., author, Overtreated; acting director, New America Foundation Health Policy Program
  • Susan Wood, PhD, George Washington University
  • Sean Flynn, JD, American University
  • Joel Lexchin, MD, York University
  • Barbara Mintzes, Therapeutics Initiative

Some of the topics:

  •  Marketing of antipsychotic medications and other drugs
  •  Potential health risks of CT scans and other medical devices
  • Legislative and regulatory updates and solutions
  •  The role of industry, media, and payers in informing and protecting patients
  • The Underuse of Classic Drugs
  • Are Medical Devices and Drugs Adequately Regulated?
  • Protecting Patients in Industry-Funded Trials
  • Pharmaceutical Marketing and Adverse Health Outcomes

Comments are closed.